Standard BioTools
LAB
LAB
107 hedge funds and large institutions have $1.15B invested in Standard BioTools in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 100 → 107 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
107
Holding in Top 10
2
Calls
$37.7M
Puts
$14.3M
Top Buyers
| 1 | +$47.6M | |
| 2 | +$19.7M | |
| 3 | +$17.4M | |
| 4 |
Jennison Associates
New York
|
+$14.4M |
| 5 |
VAM
Visium Asset Management
New York
|
+$9.64M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$15.8M | |
| 3 | -$12.9M | |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$9.7M |
| 5 |
JP Morgan Chase
New York
|
-$6.48M |